Company Profiles

driven by the PitchBook Platform

Attometrics

Description

Developer of a technology designed to detect protein, metabolite and DNA analytes. The company's technology provides rapid screening for infection by E. coli O157:H7 and other bacterial strains that produce deadly Shiga toxin proteins, enabling physicians for detecting biomarkers to identify potential cancers and infectious diseases.

PRIVATE

Status

Seed

Latest Deal Type

$25k

Latest Deal Amount

$25k

Total Amount Raised

1

Investors

Description

Developer of a technology designed to detect protein, metabolite and DNA analytes. The company's technology provides rapid screening for infection by E. coli O157:H7 and other bacterial strains that produce deadly Shiga toxin proteins, enabling physicians for detecting biomarkers to identify potential cancers and infectious diseases.

Website:

www.biomarker-diagnostics.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Diagnostic Equipment

Primary Office

15013 South 24th Way Phoenix, AZ 85048United States +1 (480) 382-8660
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Attometrics's full profile, request a free trial.

    Attometrics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Attometrics Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    ASU Venture CatalystAccelerator/IncubatorMinority000 0000000 0000
    ASU Venture Catalyst Accelerator/Incubator

    Attometrics Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Wayne FraschFounder & Chief Executive Officer
    Wayne Frasch Founder & Chief Executive Officer
    Request full access to PitchBook